Skip to content
10-Q

Quarterly Report

AVANOS MEDICAL, INC. AVNS

0001606498-26-000063

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 28, 2026 46.82M sh
Shares Diluted Q1 2026 · Mar 31, 2026 47.5M sh
Shares Diluted Q1 2026 · Mar 31, 2025 46.8M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $1.3M
Stock Repurchased Q1 2026 · Mar 31, 2025 $2.2M
Capex Q1 2026 · Mar 31, 2026 $4.3M
Capex Q1 2026 · Mar 31, 2025 $6.7M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$12.3M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $25.7M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $65.6M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $89.8M
Stockholders Equity Q1 2026 · Mar 31, 2026 $782.1M
Stockholders Equity Q1 2026 · Dec 31, 2025 $778.2M
Stockholders Equity Q1 2026 · Mar 31, 2025 $839.4M
Current Liabilities Q1 2026 · Mar 31, 2026 $131.2M
Current Liabilities Q1 2026 · Dec 31, 2025 $165.2M
Total Liabilities Q1 2026 · Mar 31, 2026 $268M
Total Liabilities Q1 2026 · Dec 31, 2025 $295.5M
Current Assets Q1 2026 · Mar 31, 2026 $325M
Current Assets Q1 2026 · Dec 31, 2025 $355.4M
Total Assets Q1 2026 · Mar 31, 2026 $1.05B
Total Assets Q1 2026 · Dec 31, 2025 $1.07B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.11
Eps Diluted Q1 2026 · Mar 31, 2025 $0.14
Eps Basic Q1 2026 · Mar 31, 2026 $0.11
Eps Basic Q1 2026 · Mar 31, 2025 $0.14
Sga Expense Q1 2026 · Mar 31, 2026 $77.7M
Sga Expense Q1 2026 · Mar 31, 2025 $75.7M
Rd Expense Q1 2026 · Mar 31, 2026 $5.2M
Rd Expense Q1 2026 · Mar 31, 2025 $5.4M
Net Income Q1 2026 · Mar 31, 2026 $5.1M
Net Income Q1 2026 · Mar 31, 2025 $6.6M
Operating Income Q1 2026 · Mar 31, 2026 $8.9M
Operating Income Q1 2026 · Mar 31, 2025 $10.3M
Gross Profit Q1 2026 · Mar 31, 2026 $94.2M
Gross Profit Q1 2026 · Mar 31, 2025 $89.8M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $88M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $77.7M
Revenue Q1 2026 · Mar 31, 2026 $182.2M
Revenue Q1 2026 · Mar 31, 2025 $167.5M